Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q59160761
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010844.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q59160761
|
024
|
|
|
‡a
0000-0002-7331-9157
‡2
orcid
|
024
|
|
|
‡a
57064454800
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q59160761
|
100
|
0 |
|
‡a
Diana Dias da Silva
‡c
researcher ORCID ID = 0000-0002-7331-9157
‡9
en
|
375
|
|
|
‡a
2
‡2
iso5218
|
400
|
0 |
|
‡a
Diana Dias da Silva
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's A multiparametric study of gold nanoparticles cytotoxicity, internalization and permeability using an in vitro model of blood-brain barrier. Influence of size, shape and capping agent
|
670
|
|
|
‡a
Author's An insight into the hepatocellular death induced by amphetamines, individually and in combination: the involvement of necrosis and apoptosis
|
670
|
|
|
‡a
Author's Benzo fury: A new trend in the drug misuse scene
|
670
|
|
|
‡a
Author's Biodistribution and metabolic profile of 3,4-dimethylmethcathinone (3,4-DMMC) in Wistar rats through gas chromatography-mass spectrometry (GC-MS) analysis
|
670
|
|
|
‡a
Author's Diet aid or aid to die: an update on 2,4-dinitrophenol (2,4-DNP) use as a weight-loss product
|
670
|
|
|
‡a
Author's Emerging club drugs: 5-(2-aminopropyl)benzofuran (5-APB) is more toxic than its isomer 6-(2-aminopropyl)benzofuran (6-APB) in hepatocyte cellular models
|
670
|
|
|
‡a
Author's Ethanol addictively enhances the in vitro cardiotoxicity of cocaine through oxidative damage, energetic deregulation, and apoptosis
|
670
|
|
|
‡a
Author's Hepatotoxicity of piperazine designer drugs: Comparison of different in vitro models
|
670
|
|
|
‡a
Author's Impact of in Vitro Gastrointestinal Digestion and Transepithelial Transport on Antioxidant and ACE-Inhibitory Activities of Brewer's Spent Yeast Autolysate
|
670
|
|
|
‡a
Author's In vitro hepatotoxicity of 'Legal X': the combination of 1-benzylpiperazine (BZP) and 1-(m-trifluoromethylphenyl)piperazine (TFMPP) triggers oxidative stress, mitochondrial impairment and apoptosis.
|
670
|
|
|
‡a
Author's In vitro neurotoxicity evaluation of piperazine designer drugs in differentiated human neuroblastoma SH-SY5Y cells
|
670
|
|
|
‡a
Author's Piperazine designer drugs are cytotoxic to human neuroblastoma SH-SY5Y cells
|
670
|
|
|
‡a
Author's Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
|
670
|
|
|
‡a
Author's The new psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone) induces oxidative stress, apoptosis, and autophagy in primary rat hepatocytes at human-relevant concentrations
|
670
|
|
|
‡a
Author's The novel psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone): A review
|
670
|
|
|
‡a
Author's The risky cocktail: what combination effects can we expect between ecstasy and other amphetamines?
|
670
|
|
|
‡a
Author's The Synthetic Cannabinoids THJ-2201 and 5F-PB22 Enhance In Vitro CB1 Receptor-Mediated Neuronal Differentiation at Biologically Relevant Concentrations
|
670
|
|
|
‡a
Author's Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact
|
909
|
|
|
‡a
(orcid) 0000000273319157
‡9
1
|
909
|
|
|
‡a
(scopus) 57064454800
‡9
1
|
919
|
|
|
‡a
riskycocktailwhatcombinationeffectscanweexpectbetweenecstasyandotheramphetamines
‡A
The risky cocktail: what combination effects can we expect between ecstasy and other amphetamines?
‡9
1
|
919
|
|
|
‡a
syntheticcannabinoidsthj2201and5fpb22enhanceinvitrocb1receptormediatedneuronaldifferentiationatbiologicallyrelevantconcentrations
‡A
The Synthetic Cannabinoids THJ-2201 and 5F-PB22 Enhance In Vitro CB1 Receptor-Mediated Neuronal Differentiation at Biologically Relevant Concentrations
‡9
1
|
919
|
|
|
‡a
toxicokineticsandtoxicodynamicsofayahuascaalkaloidsnndimethyltryptaminedmtharmineharmalineandtetrahydroharmineclinicalandforensicimpact
‡A
Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact
‡9
1
|
919
|
|
|
‡a
multiparametricstudyofgoldnanoparticlescytotoxicityinternalizationandpermeabilityusinganinvitromodelofbloodbrainbarrierinfluenceofsizeshapeandcappingagent
‡A
A multiparametric study of gold nanoparticles cytotoxicity, internalization and permeability using an in vitro model of blood-brain barrier. Influence of size, shape and capping agent
‡9
1
|
919
|
|
|
‡a
insightintothehepatocellulardeathinducedbyamphetaminesindividuallyandincombinationtheinvolvementofnecrosisandapoptosis
‡A
An insight into the hepatocellular death induced by amphetamines, individually and in combination: the involvement of necrosis and apoptosis
‡9
1
|
919
|
|
|
‡a
benzofuryanewtrendinthedrugmisusescene
‡A
Benzo fury: A new trend in the drug misuse scene
‡9
1
|
919
|
|
|
‡a
biodistributionandmetabolicprofileof34dimethylmethcathinone34dmmcinwistarratsthroughgaschromatographymassspectrometrygcmsanalysis
‡A
Biodistribution and metabolic profile of 3,4-dimethylmethcathinone (3,4-DMMC) in Wistar rats through gas chromatography-mass spectrometry (GC-MS) analysis
‡9
1
|
919
|
|
|
‡a
dietaidoraidtodieanupdateon24dinitrophenol24dnpuseasaweightlossproduct
‡A
Diet aid or aid to die: an update on 2,4-dinitrophenol (2,4-DNP) use as a weight-loss product
‡9
1
|
919
|
|
|
‡a
emergingclubdrugs52aminopropylbenzofuran5apbismoretoxicthanitsisomer62aminopropylbenzofuran6apbinhepatocytecellularmodels
‡A
Emerging club drugs: 5-(2-aminopropyl)benzofuran (5-APB) is more toxic than its isomer 6-(2-aminopropyl)benzofuran (6-APB) in hepatocyte cellular models
‡9
1
|
919
|
|
|
‡a
ethanoladdictivelyenhancestheinvitrocardiotoxicityofcocainethroughoxidativedamageenergeticderegulationandapoptosis
‡A
Ethanol addictively enhances the in vitro cardiotoxicity of cocaine through oxidative damage, energetic deregulation, and apoptosis
‡9
1
|
919
|
|
|
‡a
hepatotoxicityofpiperazinedesignerdrugscomparisonofdifferentinvitromodels
‡A
Hepatotoxicity of piperazine designer drugs: Comparison of different in vitro models
‡9
1
|
919
|
|
|
‡a
impactofinvitrogastrointestinaldigestionandtransepithelialtransportonantioxidantandaceinhibitoryactivitiesofbrewersspentyeastautolysate
‡A
Impact of in Vitro Gastrointestinal Digestion and Transepithelial Transport on Antioxidant and ACE-Inhibitory Activities of Brewer's Spent Yeast Autolysate
‡9
1
|
919
|
|
|
‡a
invitrohepatotoxicityoflegal10thecombinationof1benzylpiperazinebzpand11000trifluoromethylphenylpiperazinetfmpptriggersoxidativestressmitochondrialimpairmentandapoptosis
‡A
In vitro hepatotoxicity of 'Legal X': the combination of 1-benzylpiperazine (BZP) and 1-(m-trifluoromethylphenyl)piperazine (TFMPP) triggers oxidative stress, mitochondrial impairment and apoptosis.
‡9
1
|
919
|
|
|
‡a
invitroneurotoxicityevaluationofpiperazinedesignerdrugsindifferentiatedhumanneuroblastomashsy5ycells
‡A
In vitro neurotoxicity evaluation of piperazine designer drugs in differentiated human neuroblastoma SH-SY5Y cells
‡9
1
|
919
|
|
|
‡a
piperazinedesignerdrugsarecytotoxictohumanneuroblastomashsy5ycells
‡A
Piperazine designer drugs are cytotoxic to human neuroblastoma SH-SY5Y cells
‡9
1
|
919
|
|
|
‡a
raisingawarenessofnewpsychoactivesubstanceschemicalanalysisandinvitrotoxicityscreeningoflegalhighpackagescontainingsyntheticcathinones
‡A
Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
‡9
1
|
919
|
|
|
‡a
newpsychoactivesubstance3methylmethcathinone32100ormetaphedroneinducesoxidativestressapoptosisandautophagyinprimaryrathepatocytesathumanrelevantconcentrations
‡A
The new psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone) induces oxidative stress, apoptosis, and autophagy in primary rat hepatocytes at human-relevant concentrations
‡9
1
|
919
|
|
|
‡a
novelpsychoactivesubstance3methylmethcathinone32100ormetaphedroneareview
‡A
The novel psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone): A review
‡9
1
|
946
|
|
|
‡a
a
‡9
1
|
996
|
|
|
‡2
SUDOC|125722060
|
996
|
|
|
‡2
DNB|1223218643
|
996
|
|
|
‡2
SUDOC|189270764
|
996
|
|
|
‡2
ISNI|0000000040461937
|
996
|
|
|
‡2
PTBNP|1599656
|
996
|
|
|
‡2
DNB|1056599294
|
996
|
|
|
‡2
PTBNP|1410961
|
996
|
|
|
‡2
PTBNP|1797030
|
996
|
|
|
‡2
PTBNP|124496
|
996
|
|
|
‡2
PTBNP|1600838
|
996
|
|
|
‡2
ISNI|0000000067776429
|
996
|
|
|
‡2
ISNI|0000000132967441
|
996
|
|
|
‡2
PTBNP|1428868
|
996
|
|
|
‡2
PTBNP|1834101
|
996
|
|
|
‡2
ISNI|0000000111431461
|
996
|
|
|
‡2
LC|n 2008061712
|
996
|
|
|
‡2
LC|ns2019001881
|
996
|
|
|
‡2
PTBNP|1770135
|
996
|
|
|
‡2
PTBNP|1528304
|
996
|
|
|
‡2
NTA|073196290
|
996
|
|
|
‡2
DNB|1257985736
|
996
|
|
|
‡2
PTBNP|208748
|
996
|
|
|
‡2
ISNI|000000004903558X
|
996
|
|
|
‡2
BLBNB|000987703
|
996
|
|
|
‡2
LC|n 84018986
|
996
|
|
|
‡2
LC|n 2008206414
|
996
|
|
|
‡2
LC|no2013105488
|
996
|
|
|
‡2
PTBNP|1589428
|
996
|
|
|
‡2
ISNI|0000000385029381
|
996
|
|
|
‡2
PTBNP|1571868
|
996
|
|
|
‡2
PTBNP|120368
|
996
|
|
|
‡2
PTBNP|1208508
|
996
|
|
|
‡2
PTBNP|138689
|
996
|
|
|
‡2
J9U|987008729574605171
|
996
|
|
|
‡2
LC|no2023046609
|
996
|
|
|
‡2
LC|no2003061087
|
996
|
|
|
‡2
LC|no2009195650
|
996
|
|
|
‡2
ISNI|0000000023438575
|
996
|
|
|
‡2
PTBNP|1603199
|
996
|
|
|
‡2
ISNI|0000000383614114
|
996
|
|
|
‡2
LC|no2005010891
|
996
|
|
|
‡2
ISNI|0000000078143117
|
996
|
|
|
‡2
BLBNB|001526545
|
996
|
|
|
‡2
PTBNP|1610482
|
996
|
|
|
‡2
CAOONL|ncf11912434
|
996
|
|
|
‡2
ISNI|0000000023518313
|
996
|
|
|
‡2
PTBNP|1818705
|
996
|
|
|
‡2
SUDOC|22473556X
|
996
|
|
|
‡2
ISNI|0000000497058144
|
996
|
|
|
‡2
LC|n 2002119652
|
996
|
|
|
‡2
LC|nb2019007371
|
996
|
|
|
‡2
ISNI|0000000047875454
|
996
|
|
|
‡2
PTBNP|1784090
|
996
|
|
|
‡2
LC|no2018125466
|
996
|
|
|
‡2
SUDOC|145184145
|
996
|
|
|
‡2
LC|n 82082160
|
996
|
|
|
‡2
PLWABN|9812675013605606
|
996
|
|
|
‡2
ISNI|000000006960468X
|
996
|
|
|
‡2
PTBNP|377559
|
996
|
|
|
‡2
LC|no2019151380
|
996
|
|
|
‡2
BNE|XX5489347
|
996
|
|
|
‡2
PTBNP|1633149
|
996
|
|
|
‡2
BNF|17115685
|
996
|
|
|
‡2
NTA|071023259
|
996
|
|
|
‡2
PLWABN|9812000427105606
|
996
|
|
|
‡2
BLBNB|000173237
|
996
|
|
|
‡2
DNB|1059639254
|
996
|
|
|
‡2
NLA|000065328183
|
996
|
|
|
‡2
BLBNB|001028369
|
996
|
|
|
‡2
LC|ns2012004973
|
996
|
|
|
‡2
PLWABN|9810540271305606
|
996
|
|
|
‡2
ISNI|0000000034498602
|
996
|
|
|
‡2
ISNI|0000000387615173
|
996
|
|
|
‡2
LC|no2001018490
|
996
|
|
|
‡2
ISNI|0000000070403690
|
996
|
|
|
‡2
PTBNP|1776404
|
996
|
|
|
‡2
DNB|1139284738
|
996
|
|
|
‡2
RERO|A023505367
|
996
|
|
|
‡2
SUDOC|230606253
|
996
|
|
|
‡2
ISNI|0000000070624952
|
996
|
|
|
‡2
PTBNP|1848947
|
996
|
|
|
‡2
ISNI|0000000068990873
|
996
|
|
|
‡2
BIBSYS|8050065
|
996
|
|
|
‡2
ISNI|0000000389526537
|
996
|
|
|
‡2
ISNI|0000000038979606
|
996
|
|
|
‡2
ISNI|000000004797978X
|
996
|
|
|
‡2
RERO|A022401129
|
996
|
|
|
‡2
DNB|1105421201
|
996
|
|
|
‡2
LC|no2016081087
|
996
|
|
|
‡2
NUKAT|n 99067637
|
996
|
|
|
‡2
ISNI|0000000460121306
|
996
|
|
|
‡2
PTBNP|195668
|
996
|
|
|
‡2
RERO|A026089228
|
996
|
|
|
‡2
ISNI|0000000420552873
|
996
|
|
|
‡2
LC|n 2023254260
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|